- Added 6 May 2021
Aga Khan University Clinical Trials Unit (CTU)
Phase 3 Coronavirus Vaccine in 2900 subjects. Site previously performed Phase 2a trial for NVGH Glycoconjugate Vaccine in 160 participants, Phase 4 for mOPV1 and bOPV1&3 oral polio vaccines in 800 participants, Phase 4 evaluation of Mucosal Immunity to Polioviruses Following Administration of bOPV and IVP in 1250 participants, Phase 4 evaluation of immunogenicity of Rotavirus Vaccines provided on different schedules and with/without breastfeeding in 1140 participants.
Co-PI previously performed trial 1 to evaluate malaria vaccine in 75 subjects and phase 4 of rotavirus vaccine in 1140 subjects"
- Enteric diseases
Contact this site
To: Saeed Hamid, Principal Investigator at Aga Khan University Clinical Trials Unit (CTU)Please Login to contact a site.